Method of Producing Infectious Papillomavirus in Placental Cells

Applications: method of producing infectious papillomavirus in vitro and methods of making recombinant papillomavirus for vaccines

This invention is an improved method of producing infectious papillomavirus in vitro, with a method comprising (a) introducing papillomavirus or papillomavirus DNA or portions thereof necessary for replication, into an epithelial cell; and (b) providing conditions that produce papillomavirus, wherein the conditions comprise not contacting the epithelial cell a fibroblast and does not comprise an organotypic raft culture or a dermal equivalent.

This invention also discloses a papillomavirus infected non-keratinocyte epithelial cell produced by the methods of the present invention. Further, uses of the disclosed method includes detection methods, methods for screening anti-papillomavirus drugs, methods of making recombinant papillomavirus for vaccines and studying the life cycle. Additionally, a method of reducing and assessing the risk of spontaneous abortion is disclosed.

U.S. Patent #6,495,361

Available for Exclusive Licensing

00-20 Hermonat

Claims:

1. A method of producing infectious papillomavirus in vitro, wherein said method comprises: (a) introducing papillomavirus or papillomavirus DNA into a placental cell; and (b) providing conditions sufficient for the production of said papillomavirus in said placental cell.

2. The method of claim 1, wherein said placental cell is selected from the group consisting of a trophoblast, a cytotrophoblast, a syncytiotrohoblast, a hyperplastic or displastic trophoblast and a choriocarcinoma.

3. The method of claim 1, wherein said introducing of said papillomavirus or said papillomavirus DNA into said placental cell is performed by one of the methods selected from the group consisting of transfecting into, lipofecting into, electroporating into and contacting with said papillomavirus or papillomavirus DNA.

4. The method of claim 1, wherein said papillomavirus DNA is papillomavirus genomic DNA.

5. The method of claim 1, wherein said papillomavirus DNA is mutant DNA, and when expressed in said placental cell, results in an attenuated or defective papillomavirus.

6. The method of claim 1, wherein said papillomavirus is a human papillomavirus.

7. The method of claim 1, further comprising © detecting the presence of papillomavirus.

No known limitations

File Number: 00-20 

Web site: http://www.uams.edu/bioventures

Disease: Infectious Diseases

Other Information:

Patent Claims:

1. A method of producing infectious papillomavirus in vitro, wherein said method comprises: (a) introducing papillomavirus or papillomavirus DNA into a placental cell; and (b) providing conditions sufficient for the production of said papillomavirus in said placental cell.

2. The method of claim 1, wherein said placental cell is selected from the group consisting of a trophoblast, a cytotrophoblast, a syncytiotrohoblast, a hyperplastic or displastic trophoblast and a choriocarcinoma.

3. The method of claim 1, wherein said introducing of said papillomavirus or said papillomavirus DNA into said placental cell is performed by one of the methods selected from the group consisting of transfecting into, lipofecting into, electroporating into and contacting with said papillomavirus or papillomavirus DNA.

4. The method of claim 1, wherein said papillomavirus DNA is papillomavirus genomic DNA.

5. The method of claim 1, wherein said papillomavirus DNA is mutant DNA, and when expressed in said placental cell, results in an attenuated or defective papillomavirus.

6. The method of claim 1, wherein said papillomavirus is a human papillomavirus.

7. The method of claim 1, further comprising © detecting the presence of papillomavirus.